Behavioral Health Outcomes
Focus on Decreasing Opioids Misuse
RAZR’s focus is to engage providers and acute care, short-stay hospitals including those within 414 community-based coalitions and 6.8 million Medicare beneficiaries to improve access to behavioral care and improve behavioral health outcomes with the goal of decreasing opioids misuse. A CDC study showed that between 1999 and 2015 drug overdoses increased 325% in rural areas compared to 198% in urban. We are committed to improving the care of vulnerable populations in areas with medical care access challenges as it correlates to the national opioid misuse and overdose issues across the U.S.
RAZR offers in-depth expertise in advanced data analytics to detect opioids prescribing outliers. We currently collaborate with the FDA using data algorithms and machine learning techniques to effectively lower high dosage opioids prescriptions. We use advanced data analytics including machine learning predictive modeling to track strategic targets for achieving our goal on decreasing opioids misuse:
Target 1 – Decrease Opioid-Related Adverse Events
- Decrease opioid adverse events, including deaths in recruited acute care hospitals and providers.
- Promote current best practices and patient-centered.
Target 2 – Decrease High Dose Opioid Prescribing
- Decrease opioid prescribing (for prescriptions ≥ 90 MME daily across recruited acute care hospitals and providers.
- Promote transparency in the measurement process.
Target 3 – Decrease Opioid-Related Adverse Events
- Promote the use of alternative therapies for pain management.
- Treat chronic pain without opioids.